LCTX
Lineage Cell Therapeutics, Inc. · Healthcare
Broadwood Partners, L.P. bought $1.3M of Lineage Cell Therapeutics, Inc.
Director and 10% owner
Bought$1,317,667
$1.42Price
930,106Shares
+1%Stake
What LCTX did for a copier
- $1,000 copied at Mon, Mar 28 open, $1.59
- $811
- S&P 500, same days
- −11.7%
Measured over 30 trading days, to the May 10 close.
Broadwood Partners, L.P.'s record
28 other buys with 3 months of prices since 2018: on average −1.7% against the S&P 500, and 11 of 28 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Mar 23. Filed Fri, Mar 25, 5:56 PM ET, after the close. Returns use the Mar 28 open and the May 10 close. Not investment advice.